Showing results (131-140 of 207) with videos related to
Sort By:
Pageof 21
Journal of the American Pharmacists Association : Japha|October 9, 2025
The Minivisit Method: Adapting Opioid-Related Educational Outreach for Community PharmaciesMonica F Roberts, Patricia R Freeman, Laura K Stinson, et al.Health & Justice|February 6, 2021
Adaptation of a standard extended-release naltrexone (XR-NTX) protocol for rural re-entering offenders with OUDMichele Staton, Hannah K Knudsen, Sharon L Walsh, et al.Clinical Pharmacology and Therapeutics|August 4, 2004
Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-alpha-methadol in opioid-naive individualsDavid E Moody, Sharon L Walsh, Douglas E Rollins, et al.Journal of Substance Use and Addiction Treatment|December 22, 2025
Cigarette use and smoking cessation goals among pregnant women with opioid use disorderElizabeth E Krans, Daniel Lewis, Antoine Douaihy, et al.Contemporary Clinical Trials|March 19, 2021
The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED InnovationGail D'Onofrio, Kathryn F Hawk, Andrew A Herring, et al.Journal of Substance Use and Addiction Treatment|April 6, 2023
Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs studyFrankie B Kropp, Marcela C Smid, Michelle R Lofwall, et al.Journal of Opioid Management|September 10, 2009
Prescription drug fatalities among women in rural Virginia: a study of medical examiner casesMartha J Wunsch, Kent Nakamoto, Paul A Nuzzo, et al.Psychopharmacology|June 26, 2010
Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusersAngela N Duke, Christopher J Correia, Sharon L Walsh, et al.Addiction (Abingdon, England)|September 28, 2005
Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteersEric C Donny, Susan M Brasser, George E Bigelow, et al.Experimental and Clinical Psychopharmacology|June 8, 2006
Assessment of agonist and antagonist effects of tramadol in opioid-dependent humansC Patrick Carroll, Sharon L Walsh, George E Bigelow, et al.Pageof 21